Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
17.06.24
/
50%
€26.62
Target price
17.06.25
€60.58
Performance (%)
137.04%
End price
18.06.25
€63.10
Summary
This prediction ended on 18.06.25 with a price of €63.10. With a performance of 137.04% the BUY prediction by Truist_Financial_Co_ was a big success. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corcept Therapeutics Inc. | -2.960% | -2.960% | -40.887% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $65.00 price target on the stock.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€93.70
31.03.25
31.03.25
€138.36
31.03.26
31.03.26
-63.13%
01.04.26
01.04.26
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.88
30.09.24
30.09.24
€68.09
30.09.25
30.09.25
66.38%
01.10.25
01.10.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.31
04.06.24
04.06.24
€59.79
04.06.25
04.06.25
104.22%
05.06.25
05.06.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.88
02.05.24
02.05.24
€41.15
02.05.25
02.05.25
181.82%
03.05.25
03.05.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.60
16.02.24
16.02.24
€39.06
16.02.25
16.02.25
204.07%
17.02.25
17.02.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
06.11.23
06.11.23
€35.38
06.11.24
06.11.24
112.42%
07.11.24
07.11.24

